RBC Raises Price Target on Veeva Systems to $365 From $325
RBC Capital Markets increased its price target for Veeva Systems to $365 from $325 while maintaining an Outperform rating.
Stocks · News reference
Veeva Systems Receives 'Overall BioTech Solution of the Year' Award
Veeva Systems was honored with the 'Overall BioTech Solution of the Year' award for its 'Veeva Basics' offering by the BioTech Breakthrough Awards program.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stifel Adjusts Price Target on Veeva Systems to $340
Stifel has adjusted its price target for Veeva Systems Inc. to $340 from $300.
Needham Maintains Buy on Veeva Systems, Raises Price Target to $360
Needham analyst maintained a Buy rating on Veeva Systems and increased the price target from $310 to $360.
8-K filing — VEEVA SYSTEMS INC (VEEV)
Filed: 2026-11-06 AccNo: 0001393052-26-000039 Size: 298 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
UCB Selects Veeva Vault CRM for Agentic Engagement
Veeva Systems announced that pharmaceutical company UCB has committed to adopting Vault CRM, the company's agentic engagement platform for the life sciences industry.
Tom Schwenger Departs Veeva Systems to Become CEO of Omnicom Health Marketing
Tom Schwenger, who served as President and Chief Customer Officer at Veeva Systems, has left the company to lead Omnicom Health's marketing business.